J. Lamont

发表

Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B

R. Gilbert, C. Pothoulakis, E. Rubin, 1995, Infection and immunity.

The Insect Peptide CopA3 Increases Colonic Epithelial Cell Proliferation and Mucosal Barrier Function to Prevent Inflammatory Responses in the Gut*

C. Pothoulakis, Ho Kim, Junguee Lee, 2015, The Journal of Biological Chemistry.

Clostridium difficile infection.

C. Kelly, Katharine A. Germansky, J. Lamont, 2015, The New England journal of medicine.

Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life.

T. Lamont, Sushrut Jangi, J. Lamont, 2010, Journal of pediatric gastroenterology and nutrition.

A 69-year-old woman presenting to the hospital with 48 hours of abdominal pain and diarrhea.

D. Leffler, J. Lamont, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine

C. Pothoulakis, C. Kelly, A. Fatimi, 1999, Gut.

Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract

C. Pothoulakis, C. Kelly, S. Keates, 1997, Antimicrobial agents and chemotherapy.

Protein Kinase C Signaling Regulates ZO-1 Translocation and Increased Paracellular Flux of T84 Colonocytes Exposed toClostridium difficile Toxin A*

C. Pothoulakis, Ming L. Chen, J. Lamont, 2002, The Journal of Biological Chemistry.

Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease.

Y. Trnka, J. Lamont, 1981, Gastroenterology.

p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.

C. Pothoulakis, C. Kelly, S. Keates, 2000, The Journal of clinical investigation.

Differential effects of Clostridium difficile toxins A and B on rabbit ileum.

M. O'brien, C. Pothoulakis, G. Triadafilopoulos, 1987, Gastroenterology.

Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum.

R. Eliakim, C. Pothoulakis, D. Rachmilewitz, 1993, Gastroenterology.

Effect of Chondroitinase ABC on Purulent Sputum from Cystic Fibrosis and Other Patients

I. Khatri, K. Bhaskar, J. Forstner, 2003, Pediatric Research.

Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine.

C. Pothoulakis, J. Paulson, D. Anderson, 1994, The Journal of clinical investigation.

Clostridium difficile Toxin A-induced Microvascular Dysfunction

C. Pothoulakis, J. Paulson, M. Miyasaka, 1994 .

The Insect Peptide Coprisin Prevents Clostridium difficile-Mediated Acute Inflammation and Mucosal Damage through Selective Antimicrobial Activity

C. Pothoulakis, Ho Kim, E. Yun, 2011, Antimicrobial Agents and Chemotherapy.

Clostridium difficile Infection and Pseudomembranous Colitis

A. Moss, J. Lamont, 2010 .

Antibiotic-Associated Diarrhea, Pseudomembranous Enterocolitis, and Clostridium difficile-Associated Diarrhea and Colitis

C. Kelly, J. Lamont, 2010 .

Clostridium difficile toxin A binds colonocyte Src causing dephosphorylation of focal adhesion kinase and paxillin.

C. Pothoulakis, S. Rhee, Ho Kim, 2009, Experimental cell research.

Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficileToxin A in Mice

C. Pothoulakis, C. Kelly, P. Michetti, 2001, Infection and Immunity.

Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis.

R. Farrell, J. Lamont, 2000, Current topics in microbiology and immunology.

Intravenous immunoglobulin therapy for severe Clostridium di Y cile colitis

C. Pothoulakis, C. Kelly, S. Keates, 1998 .

Recent advances in the structure and function of Clostridium difficile toxins

J. Lamont, 1996 .

Clostridium difficile cytotoxin inhibits protein synthesis in fibroblasts and intestinal mucosa.

C. Pothoulakis, G. Triadafilopoulos, C. Franzblau, 1986, Gastroenterology.

Clostridium difficile Toxin A Regulates Inducible Cyclooxygenase-2 and Prostaglandin E2 Synthesis in Colonocytes via Reactive Oxygen Species and Activation of p38 MAPK*

T. Savidge, C. Pothoulakis, M. Moyer, 2005, Journal of Biological Chemistry.

Clostridium difficile toxin B activates calcium influx required for actin disassembly during cytotoxicity.

R. Gilbert, C. Pothoulakis, M. Yakubovich, 1995, The American journal of physiology.

Effect of purified Clostridium difficile toxins on intestinal smooth muscle. I. Toxin A.

C. Giampaolo, R. Gilbert, C. Pothoulakis, 1989, The American journal of physiology.

Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins.

C. Pothoulakis, J. Lamont, C. Pothoulakis, 2001, American journal of physiology. Gastrointestinal and liver physiology.

Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum.

C. Pothoulakis, T. Theoharides, I. Castagliuolo, 1994, Gastroenterology.

Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio choleare enterotoxin.

I. Castagliuolo, C. Kelly, J. Lamont, 1994 .

Purification and properties of Clostridium difficile cytotoxin B.

C. Pothoulakis, C. Franzblau, B. Faris, 1986, The Journal of biological chemistry.

Dysregulation of proteoglycan production by intrahepatic biliary epithelial cells bearing defective (Delta‐f508) cystic fibrosis transmembrane conductance regulator

Bradley S. Turner, D. Jefferson, K. Bhaskar, 1998, Hepatology.

Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.

C. Pothoulakis, J. Rubins, T. Theoharides, 1991, The Journal of clinical investigation.

IL-11 inhibits Clostridium difficile toxin A enterotoxicity in rat ileum.

C. Pothoulakis, S. Nikulásson, I. Castagliuolo, 1997, The American journal of physiology.

Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins

C. Pothoulakis, C. Kelly, S. Keates, 1996, Antimicrobial agents and chemotherapy.

Protein Kinase C Signaling Regulates ZO-1 Translocation and Increased Paracellular Flux of T84 Colonocytes Exposed to Clostridium difficile Toxin A*

C. Pothoulakis, Ming L. Chen, J. Lamont, 2002 .

CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

C. Pothoulakis, S. Leeman, I. Castagliuolo, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.

C. Pothoulakis, T. Meshulam, G. Triadafilopoulos, 1988, The Journal of clinical investigation.

Inactivation of Clostridium difficile cytotoxin by the neutrophil myeloperoxidase system.

W. Ooi, R. Clark, H. Levine, 1984, The Journal of infectious diseases.

Nerves and Intestinal Mast Cells Modulate Responses to Enterotoxins.

C. Pothoulakis, I. Castagliuolo, J. Lamont, 1998, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

C. difficile toxin A increases intestinal permeability and induces Cl- secretion.

C. Pothoulakis, J. Madara, S. Carlson, 1990, The American journal of physiology.

Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin.

C. Pothoulakis, M. Boguniewicz, C. Kelly, 1991, The Journal of pediatrics.

Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.

J. Lamont, 2002, Transactions of the American Clinical and Climatological Association.

Non-antibiotic therapy for Clostridium difficile infection.

Subhas Banerjee, J. Lamont, 2000, Current opinion in infectious diseases.

Pathophysiology, diagnosis and treatment of Clostridium difficile infection.

I. Castagliuolo, J. Lamont, 1999, The Keio journal of medicine.

Recent Advances in Clostridium difficile and its Toxins: Report of a Workshop held at Tours, France, 4 May, 1995

T. Wilkins, J. Lamont, 1995 .

Recent Advances in Clostridium difficile and its Toxins

T. Wilkins, J. Lamont, 1994 .

Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.

C. Pothoulakis, C. Kelly, I Castagliuolo, 1993, Gastroenterology.

Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum

C. Pothoulakis, S. Nikulásson, I Castagliuolo, 1996, Infection and immunity.

Selective killing of cancer cells by β-lapachone: Direct checkpoint activation as a strategy against cancer

Xiangao Sun, A. Pardee, C. Li, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Microbial factors in inflammatory bowel disease.

R. Farrell, J. Lamont, R. J. Farrell, 2002, Gastroenterology clinics of North America.

Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.

C. Pothoulakis, J. Madara, G. Hecht, 1988, The Journal of clinical investigation.

Treatment of gastrointestinal infections.

S. Banerjee, J. Lamont, Subhas Banerjee, 2000, Gastroenterology.

Role of clostridial toxin in the pathogenesis of clindamycin colitis in rabbits.

E. Sonnenblick, J. Lamont, S. Rothman, 1979, Gastroenterology.

Clostridium difficile infection.

D. Leffler, J. T. Lamont, Daniel A Leffler, 2015, The New England journal of medicine.

Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation.

Dan He, Sarah Keates, C. Pothoulakis, 2002, Gastroenterology.

Epidermal growth factor attenuates Clostridium difficile toxin A- and B-induced damage of human colonic mucosa.

C. Pothoulakis, R. Sedivy, E. Wenzl, 1997, American journal of physiology. Gastrointestinal and liver physiology.

Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.

Esther Jacobowitz Israel, C. Pothoulakis, W. Walker, 1992, The Journal of clinical investigation.

Clostridium difficile colitis.

C. Pothoulakis, C. Kelly, J. Lamont, 1994, The New England journal of medicine.

Clostridium difficile colitis and diarrhea.

C. Pothoulakis, J. Lamont, 1993, Gastroenterology clinics of North America.

Clostridium difficile colitis

J. Lamont, J. Lamont, 2004, European Surgery.

Clostridium difficile Infection: A Worldwide Disease

Kristin E. Burke, J. Lamont, 2014, Gut and liver.

Fecal Transplantation for Recurrent Clostridium difficile Infection in Older Adults: A Review

Kristin E. Burke, J. Lamont, 2013, Journal of the American Geriatrics Society.

Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.

C. Pothoulakis, Joanne, C. O'keane, 1994, The Journal of clinical investigation.

Macrophage-dependent stimulation of T cell-depleted spleen cells by Clostridium difficile toxin A and calcium ionophore.

C. Pothoulakis, T. Rothstein, P. D. Miller, 1990, Cellular immunology.

Colorectal cancer. Risk factors and screening strategies.

J. T. Lamont, J. R. Moore, J. Lamont, 1984, Archives of internal medicine.

Nitric oxide inhibits rat intestinal secretion by Clostridium difficile toxin A but not Vibrio cholerae enterotoxin.

C. Pothoulakis, I. Castagliuolo, B. Qiu, 1996, Gastroenterology.

Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A.

R. Gilbert, C. Pothoulakis, S. Nikulásson, 1996, The Journal of clinical investigation.

Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa

J. Thomas LaMont, C. Pothoulakis, Charalabos Pothoulakis, 1999, Infection and Immunity.

Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes.

Xi Na, C. Pothoulakis, H. Koon, 2005, Gastroenterology.

Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.

Xi Na, C. Pothoulakis, M. Moyer, 2005, Gastroenterology.

Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells.

B. Halmos, C. Pothoulakis, B. Agarwal, 2002, Carcinogenesis.

Clostridium difficile-associated diarrhea and colitis: pathogenesis and therapy.

C. Pothoulakis, J. T. Lamont, I. Castagliuolo, 1993, International journal of antimicrobial agents.

Clostridium difficile toxin B disrupts the barrier function of T84 monolayers.

C. Pothoulakis, J. Madara, G. Hecht, 1992, Gastroenterology.

Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction.

C. Pothoulakis, E. Chang, M. Musch, 2003, American journal of physiology. Cell physiology.

Clostridia in Gastrointestinal disease

J. Lamont, 1986 .

Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand.

C. Pothoulakis, S. Rhee, J Thomas Lamont, 2007, Gastroenterology.

Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats.

C. Pothoulakis, S. Nikulásson, Charalabos Pothoulakis, 1999, American journal of physiology. Gastrointestinal and liver physiology.

Clostridium difficile--more difficult than ever.

C. Kelly, Ciarán P Kelly, J Thomas LaMont, 2008, The New England journal of medicine.

Genetically engineered probiotics: a new twist on an old remedy.

J. T. Lamont, Claribel P Taylor, J. Lamont, 2005, Gastroenterology.

H. Hatabu, M. Nishino, L. Sholl, 2015, The New England journal of medicine.

Treatment of antibiotic-associated diarrhea caused by Clostridium difficile

S. Calderwood, C. Kelly, J. Lamont, 2010 .

Current Concepts Clostridium difficile — More Difficult Than Ever

C. Kelly, J. Lamont, 2008 .

Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells.

C. Pothoulakis, S. Nikulásson, C. Kelly, 1998, Journal of immunology.

Clostridium difficile toxin A causes early damage to mitochondria in cultured cells.

C. Pothoulakis, J T LaMont, C Pothoulakis, 2000, Gastroenterology.

Overview of Clostridium difficile infection: implications for China

Xinhua Chen, J. Lamont, 2013, Gastroenterology report.

THERAPEUTIC IMPLICATIONS OF CLOSTRIDIUM DIFFICILE TOXIN DURING RELAPSE OF CHRONIC INFLAMMATORY BOWEL DISEASE

Y. Trnka, J. Lamont, 1980, The Lancet.

Clostridium difficile Infection.

D. Leffler, J. Lamont, Dan L. Longo, 2015, The New England journal of medicine.

Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.

R Sedivy, C. Pothoulakis, R. Sedivy, 1995, The Journal of clinical investigation.

Counterimmunoelectrophoresis vs. cytotoxicity assay for the detection of Clostridium difficile toxin.

H. Levine, M. Kennedy, J. Lamont, 1982, The Journal of infectious diseases.

A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum.

C. Pothoulakis, S. Nikulásson, I. Castagliuolo, 1996, Gastroenterology.

Intravenous immunoglobulin therapy for severe Clostridium difficile colitis

C. Pothoulakis, C. Kelly, S. Keates, 1997, Gut.

Diagnostic tests for Clostridium difficile diarrhoea and colitis: Past, present and future

C. Pothoulakis, I. Castagliuolo, J. Lamont, 1993, Journal of gastroenterology and hepatology.

Clostridium difficile diarrhea: pathogenesis, epidemiology, and treatment.

R. Mitty, J. Lamont, 1994, The Gastroenterologist.

Editorial: Not So Nosocomial Anymore: The Growing Threat of Community-Acquired Clostridium difficile

D. Leffler, J. Lamont, 2012, The American Journal of Gastroenterology.

Experimental clindamycin-associated colitis in rabbits: Evidence for toxin-mediated mucosal damage

E. Sonnenblick, J. S. Trier, S. Rieth, 1978 .

Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage.

S. Broitman, E. Sonnenblick, J. S. Trier, 1978, Gastroenterology.

Rat Intestinal Epithelial Cells ProductionMacrophage-Inflammatory Protein-2 Toxin A Stimulates Clostridium difficile

C. Pothoulakis, S. Nikulásson, C. Kelly, 1998 .

Recurrent clostridium difficile.

S. Maroo, J. Lamont, 2006, Gastroenterology.

Effects of purified Clostridium difficile toxin A in the small intestine of the rat in vivo.

C. Pothoulakis, J T LaMont, C Pothoulakis, 1993, Natural toxins.

Treatment of Clostridium difficile-associated disease.

D. Leffler, J. T. Lamont, Daniel A Leffler, 2009, Gastroenterology.

Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum.

C. Giampaolo, C. Pothoulakis, G. Triadafilopoulos, 1989, Gastroenterology.

COLD AGGLUTININS IN PNEUMONIA

J. Lamont, 1969 .

Fecal Microbiota Transplantation for Primary Clostridium difficile Infection.

H. Adami, M. Bretthauer, K. Garborg, 2018, The New England journal of medicine.

Unlocking the secrets of the porcelain vase.

J. Lamont, 2000, Gastroenterology.

Adenoma detection rates vary minimally with time of day and case rank: a prospective study of 2139 first screening colonoscopies.

M. Aronson, S. Sheth, D. Leffler, 2012, Gastrointestinal endoscopy.

Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats.

C. Pothoulakis, S. Nikulásson, I. Castagliuolo, 1999, The American journal of physiology.

Clostridium difficile Toxin A Decreases Acetylation of Tubulin, Leading to Microtubule Depolymerization through Activation of Histone Deacetylase 6, and This Mediates Acute Inflammation*

C. Pothoulakis, Ho Kim, J. T. Lamont, 2010, The Journal of Biological Chemistry.

Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.

C. Pothoulakis, C. Kelly, C. Kelly, 1992, Gastroenterology.

IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes.

C. Pothoulakis, C. Kelly, S. Keates, 1997, The American journal of physiology.

gp96 Is a Human Colonocyte Plasma Membrane Binding Protein for Clostridium difficile Toxin A

C. Pothoulakis, M. Moyer, Xi Na, 2008, Infection and Immunity.

Chapter Fifty-One – Treatment of Clostridium difficile diarrhea and colitis

C. Kelly, J. Lamont, 2006 .

Saccharomyces boulardii protease inhibits Clostridium difficile toxin a and b-induced effects in human colonic mucosa

C. Pothoulakis, I. Castagliuolo, M. Riegler, 1998 .

Merde: Excursions in scientific, cultural and socio-historical coprology

J. Lamont, 2000 .

Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations

P. Portincasa, G. Garruti, L. Bonfrate, 2023, Internal and Emergency Medicine.

The renaissance of probiotics and prebiotics.

J. Lamont, 2000, Gastroenterology.

Primary afferent sensory neurons and sensory neuropeptides mediate diarrhea and intestinal inflammation

C. Pothoulakis, I. Castagliuolo, J. Lamont, 2022 .

Probiotics for Children with Gastroenteritis.

J. Lamont, 2018, The New England journal of medicine.

Experimental colon cancer.

J. Lamont, T. O’gorman, J. Lamont, 1978, Gastroenterology.

Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro

C. Pothoulakis, R. Sedivy, C. Sears, 1999, Gut.

Pathophysiology, diagnosis and treatment of Clostridium difficile infection.

I. Castagliuolo, J. Lamont, 1999, The Keio journal of medicine.

IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes.

C. Pothoulakis, C. Kelly, S. Keates, 1997, American journal of physiology. Gastrointestinal and liver physiology.

Gastrointestinal Infections: Diagnosis and Management

J. Lamont, 1997 .

IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed monocytes

C. Pothoulakis, C. Kelly, S. Keates, 1995 .